Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Tybjaerg-Hansen

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Journal of the American College of Cardiology|October 18, 2005
Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study PopulationRuth Frikke-Schmidt, Børge G Nordestgaard, Peter Schnohr, et al.
Cardiology|December 4, 2009
Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients--disease-causing or innocent bystanders?Alex Hørby Christensen, Marianne Benn, Anne Tybjaerg-Hansen, et al.
Journal of the American College of Cardiology|August 23, 2003
Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart StudyStig E Bojesen, Klaus Juul, Peter Schnohr, et al.
Atherosclerosis|September 5, 2002
Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart StudyHans H Wittrup, Børge G Nordestgaard, Rolf Steffensen, et al.
Journal of the National Cancer Institute|January 9, 2010
C-reactive protein and the risk of cancer: a mendelian randomization studyKristine H Allin, Børge G Nordestgaard, Jeppe Zacho, et al.
Circulation|February 13, 2003
Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart StudyMorten Dahl, Anne Tybjaerg-Hansen, Henrik Sillesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2006
Increased risk of breast cancer associated with CHEK2*1100delCMaren Weischer, Stig Egil Bojesen, Anne Tybjaerg-Hansen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 16, 2008
Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular diseaseJacob J Freiberg, Anne Tybjaerg-Hansen, Henrik Sillesen, et al.
Genetic Epidemiology|April 17, 2007
An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart diseaseGreg Dyson, Ruth Frikke-Schmidt, Børge G Nordestgaard, et al.
Human Genetics|September 29, 2006
Subsets of SNPs define rare genotype classes that predict ischemic heart diseaseRuth Frikke-Schmidt, Charles F Sing, Børge G Nordestgaard, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Journal of the American College of Cardiology|October 18, 2005
Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study PopulationRuth Frikke-Schmidt, Børge G Nordestgaard, Peter Schnohr, et al.
Cardiology|December 4, 2009
Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients--disease-causing or innocent bystanders?Alex Hørby Christensen, Marianne Benn, Anne Tybjaerg-Hansen, et al.
Journal of the American College of Cardiology|August 23, 2003
Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart StudyStig E Bojesen, Klaus Juul, Peter Schnohr, et al.
Atherosclerosis|September 5, 2002
Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart StudyHans H Wittrup, Børge G Nordestgaard, Rolf Steffensen, et al.
Journal of the National Cancer Institute|January 9, 2010
C-reactive protein and the risk of cancer: a mendelian randomization studyKristine H Allin, Børge G Nordestgaard, Jeppe Zacho, et al.
Circulation|February 13, 2003
Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart StudyMorten Dahl, Anne Tybjaerg-Hansen, Henrik Sillesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2006
Increased risk of breast cancer associated with CHEK2*1100delCMaren Weischer, Stig Egil Bojesen, Anne Tybjaerg-Hansen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 16, 2008
Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular diseaseJacob J Freiberg, Anne Tybjaerg-Hansen, Henrik Sillesen, et al.
Genetic Epidemiology|April 17, 2007
An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart diseaseGreg Dyson, Ruth Frikke-Schmidt, Børge G Nordestgaard, et al.
Human Genetics|September 29, 2006
Subsets of SNPs define rare genotype classes that predict ischemic heart diseaseRuth Frikke-Schmidt, Charles F Sing, Børge G Nordestgaard, et al.
Pageof 15